Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Increased
Reduced
Net increased
Funds Holding
2,894
Funds Holding Change
+8
Funds Holding Growth
+0.3%
Value
$883B
Holding in Top 10
1,283
Top 10 Change
-51
Top 10 Growth
-4%
Value Growth
-7%
New
109
Increased
1,415
Reduced
1,216
Closed
62
Capital Inflow
$27.8B
Capital Outflow
$31.4B
Net Capital Flow
-$3.61B
Capital Flow Change
-$1.25B
Calls
$11.6B
Puts
$11.6B
Net Calls
-$36.9M
Put/Call Ratio
1